Coherus Oncology, Inc. Income Statement

Income Statement Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.90M2.75M31.11M30.04M190.11M1.56M-9.68M356.07M475.82M326.55M211.04M257.24M266.96M
Cost of Revenue 17.08M37.67M57.59M70.08M158.99M117.55M
Gross Profit 1.90M2.75M31.11M30.04M190.11M1.56M-9.68M338.99M438.16M268.96M140.96M98.25M149.41M
Operating items
Research & Development 34.89M31.28M78.22M213.06M254.44M162.39M110.24M94.19M142.76M363.11M199.36M109.44M93.34M
Selling, General & Administrative 5.53M7.46M17.56M36.05M51.60M71.30M94.18M137.04M139.08M169.71M198.48M192.01M167.74M
Other Operating Expenses 17.08M37.67M57.59M-369.44M-284.57M117.55M
Operating Expenses 40.42M38.74M95.79M249.11M306.04M233.69M204.42M248.30M319.50M590.41M467.92M460.44M378.63M
Operating Income -38.52M-35.99M-64.68M-219.07M-115.93M-232.14M-204.42M107.77M156.32M-263.86M-256.88M-203.20M-111.67M
EBIT -38.52M-35.99M-64.68M-219.07M-115.93M-232.14M-204.42M107.77M156.32M-263.86M-256.88M-203.20M-111.67M
Non-operating items
Other Non Operating Income 7.01M-12.35M-18.59M-4.84M-3.88M3.40M4.69M2.61M0.55M-0.28M-6.22M5.47M-12.63M
Non Operating Income 7.01M-12.35M-18.59M-4.84M-3.88M3.40M4.69M2.61M0.55M-0.28M3.82M5.47M3.37M
Net income details
EBT -40.03M-41.29M-68.58M-219.10M-123.91M-238.29M-209.41M92.78M135.71M-287.10M-291.75M-238.27M28.51M
Tax Provisions 2.94M3.50M-0.38M
Profit After Tax -33.02M-53.63M-87.18M-223.94M-127.79M-238.29M-209.41M89.83M132.24M-287.10M-291.75M-237.89M28.51M
Income from Non-Controlling Interests -0.04M-0.68M-0.45M-0.12M-0.07M
Income from Continuing Operations -40.03M-41.29M-68.58M-219.10M-123.91M-238.29M-209.41M89.83M132.21M-287.10M-291.75M-237.89M28.51M
Consolidated Net Income -40.03M-41.29M-68.58M-219.10M-123.91M-238.29M-209.41M89.83M132.21M-287.10M-291.75M-237.89M28.51M
Income towards Parent Company -40.03M-41.29M-68.58M-219.10M-123.91M-238.29M-209.41M89.83M132.21M-287.10M-291.75M-237.89M28.51M
Net Income towards Common Stockholders -40.03M-41.29M-68.58M-219.10M-123.91M-238.29M-209.41M89.83M132.21M-287.10M-291.75M-237.89M28.51M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M0.00M-0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M0.00M-0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 33.26M38.89M51.15M57.95M69.26M70.13M72.79M76.79M77.78M111.36M115.90M
Shares Outstanding (Diluted Average) 53.13M65.03M73.19M83.49M75.45M77.63M94.16M114.83M
EBITDA -38.52M-35.99M-64.68M-219.07M-115.93M-232.14M-204.42M107.77M156.32M-263.86M-256.88M-203.20M-111.67M
Tax Rate 3.17%2.58%0.16%